Physician profile
Jon Schellack
NPI 1780675736
$2,613.61
in general payments reported to CMS, 2019-2025
22 companies · $35.25 in 2025
The $35.25 reported for 2025 was less than what a typical provider received nationally.
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $200 · 2020: $855 · 2021: $910 · 2022: $237 · 2023: $198 · 2024: $179 · 2025: $35.25.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $412.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $411.52 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Endologix LLC | $833.76 | 2020-2021 | |
| Bard Peripheral Vascular, INC. | $526.70 | 2020-2023 | Fluency Endovascular Stent Graft |
| Boston Scientific Corporation | $204.28 | 2019-2024 | Eluvia, Angiojet Ultra 5000a, Ekosonic |
| Smith+Nephew, INC. | $152.92 | 2019-2023 | Grafix Pl, Stravix |
| Janssen Pharmaceuticals, INC | $123.77 | 2019-2022 | |
| W. L. Gore & Associates, INC. | $120.24 | 2024 | Gore Tag Thoracic Endoprosthesis |
| Medtronic, INC. | $111.54 | 2022-2024 | Endurant Iis, Chameleon |
| Fresenius USA Marketing, INC. | $111.53 | 2020-2025 | Velphoro, Velphoro |
| Astrazeneca Pharmaceuticals Lp | $63.89 | 2020-2022 | |
| Shockwave Medical, INC | $54.48 | 2021-2022 | |
| Ekos Corporation | $51.63 | 2019 | |
| Biotronik INC. | $44.83 | 2022 | |
| Ethicon US, LLC | $32.08 | 2020 | |
| Mozarc Medical US LLC | $30.14 | 2023 | Argyle, Chameleon |
| E.R. Squibb & Sons, L.L.C. | $26.01 | 2019 |
Show all 22 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Trisalus Life Sciences, INC. | $25.32 | 2023 | Trinav Infusion System |
| Pacira Pharmaceuticals Incorporated | $24.49 | 2021 | |
| Artivion, INC. | $18.05 | 2019 | |
| Penumbra, INC. | $17.80 | 2023 | Smart Coil |
| Kerecis Limited | $16.21 | 2025 | Kerecis Surgiclose, Kerecis Graftguide |
| Venturemed Group, INC. | $12.24 | 2021 | |
| Pfizer INC. | $11.70 | 2019 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Jon Schellack listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.